Nippon Shinyaku CoTSE:4516 -0.25%90 Net Margin % is 8.88% as of Mar. 2026, which is 44% below its 10-year median of 15.93. GuruFocus rates TSE:4516 with a GF Score™ of 90/100 and a GF Value™ of 円4,785.64 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 956 Drug Manufacturers companies, Nippon Shinyaku Co ranks better than 83.47% on this metric.
The historical rank and industry rank for Nippon Shinyaku Co's Net Margin % or its related term are showing as below:
TSE:4516'
s Net Margin % Range Over the Past 10 Years
Min: 11.89 Med: 15.93 Max: 20.32
Current: 17.4
TSE:4516's Net Margin % is ranked better than 83.47% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs TSE:4516: 17.40
Nippon Shinyaku Co (TSE:4516) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nippon Shinyaku Co Net Margin % Related Terms
Nippon Shinyaku Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Nippon Shinyaku Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nippon Shinyaku Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nippon Shinyaku Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nippon Shinyaku Co (TSE:4516) has a Net Margin % of 8.88% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Nippon Shinyaku Co and its competitors. This is 44% below median its historical median of 15.93. Over the past decade, Nippon Shinyaku Co's Net Margin % has ranged from 11.89 to 20.32. According to the industry distribution chart, Nippon Shinyaku Co ranks #158 out of 956 companies in the Drug Manufacturers industry, placing it in the top 16.5%.
Is Nippon Shinyaku Co's Net Margin % too high?
Nippon Shinyaku Co's current Net Margin % of 8.88% is 44% below median its 10-year median of 15.93. Over the past 10 years, this metric has ranged from a low of 11.89 to a high of 20.32. The Drug Manufacturers industry median Net Margin % is 5.56. Nippon Shinyaku Co's value of 8.88% is 59.7% above this industry median. Based on the distribution chart, Nippon Shinyaku Co ranks #158 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Nippon Shinyaku Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nippon Shinyaku Co's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Nippon Shinyaku Co ranks #158 out of 956 companies for Net Margin %. This places Nippon Shinyaku Co in the top 17% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.56. Nippon Shinyaku Co's value of 8.88% is 59.7% above this benchmark. Historically, Nippon Shinyaku Co's own Net Margin % has ranged from 11.89 to 20.32 over the past decade. While the company's 10-year median is 15.93 vs. the industry median of 5.56, Nippon Shinyaku Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nippon Shinyaku Co's current Net Margin % of 8.88% is 59.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nippon Shinyaku Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nippon Shinyaku Co's current Net Margin % is 8.88%, which is 44% below median its own 10-year median of 15.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Shinyaku Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Shinyaku Co (TSE:4516) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,785.64, compared to a current price of 円4,037.00 — trading 15.6% below its estimated fair value. The current Net Margin % is 8.88%, which is 44% below median its 10-year median of 15.93 and 59.7% above the Drug Manufacturers industry median of 5.56. Nippon Shinyaku Co's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nippon Shinyaku Co (TSE:4516), the current Net Margin % is 8.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nippon Shinyaku Co (TSE:4516) Overvalued in 2026?
Based on GuruFocus' analysis, Nippon Shinyaku Co stock appears to be undervalued.
The current stock price of 円4,037.00 is trading 15.6% below its estimated GF Value™ of 円4,785.64.
GuruFocus considers Nippon Shinyaku Co to be Modestly Undervalued.
Key valuation signals for TSE:4516:
Net Margin %: 8.88% (44% below median its 10-year median of 15.93)
GF Value™: 円4,785.64 vs. price of 円4,037.00 (15.6% below fair value)
Industry Position: 59.7% above the Drug Manufacturers median (#158 of 956)
No single metric tells the full story. See the TSE:4516 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nippon Shinyaku Co Ltd is engaged in the pharmaceuticals and functional food businesses. The Pharmaceuticals Business develops and sells treatments for urological disorders, blood cancer, rare and intractable diseases, and gynecological conditions. The Functional Food Business produces and sells health food ingredients, quality-stabilizing preservatives, protein preparations, and supplements. It generates the majority of its revenue from the Pharmaceuticals segment.
90GF Score
Get the complete analysis for TSE:4516
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4516 has been successfully added to your 
